CALCA and liver cancer: Clinicians and laboratory professionals should be aware that sepsis biomarkers such as PCT or sCD14-ST/presepsin can be extremely elevated in patients with primary liver cancer due to causes other than a systemic infection – not only in patients with neuroendocrine or hepatocellular carcinoma but also in those with advanced metastatic CCA.